Sensorium Clinical Research
Sensorium Clinical Research operates a community-based clinical trial site network serving pharmaceutical sponsors, CROs, and independent site owners. It runs decentralized trial execution across six therapeutic areas while preserving local site autonomy under centralized operational and technology support.
- Company typePrivate
- Founded2025
- HeadquartersPhiladelphia, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Sensorium Clinical Research does
Sensorium Clinical Research operates a community-based clinical trial site network that serves pharmaceutical sponsors, contract research organizations (CROs), independent site owners, and clinical trial participants. The company contracts network-wide with sponsors for clinical trial execution and recruits independent sites into a partnership model in which sites retain their local brand, clinical autonomy, and equity while gaining access to centralized business development, finance, HR, payroll, compliance, patient recruitment, and regulatory operations support. The network currently spans at least three sites in California and Florida — Apex Clinical Research (San Diego), Galiz Research (Hialeah), and Quantum Clinical Research (Deerfield Beach) — with active recruitment across six therapeutic areas including neuroscience, cardiovascular, gastroenterology, metabolic, endocrinology, and dermatology. Sensorium reports 300+ completed trials and 100+ years of combined investigator experience across the network.
The underlying technology consists of centralized systems supporting clinical trial management (CTMS), electronic regulatory (eReg), and customer relationship management (CRM) workflows deployed across the site network, overlaid with multi-channel patient recruitment strategies anchored in community physician referral networks. The company is privately held and backed by Thurston Group, a healthcare-only investor with a track record of scaling 400+ locations across 12 healthcare platforms. Sensorium generates revenue through two primary streams: per-study professional services revenue from sponsors and CROs, and managed services revenue from independent sites that join the network. Patient-facing economics — study-related care at no cost with stipend compensation for time and travel — are not a revenue source but a recruitment mechanism. Specific pricing for sponsor services is negotiated on a study-by-study basis and is not publicly disclosed. The company distributes through direct enterprise sales to sponsors and CROs, a membership channel for independent site owners, and community-based patient recruitment through local site staff.
Sensorium Clinical Research firmographics
Firmographics- Name
- Sensorium Clinical Research
- Legal name
- Sensorium Clinical Research
- Website
- https://sensoriumcr.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Sensorium Clinical Research operates a community-based clinical trial site network serving pharmaceutical sponsors, CROs, and independent site owners. It runs decentralized trial execution across six therapeutic areas while preserving local site autonomy under centralized operational and technology support.
- Ownership category
- akta.pro rank
Sensorium Clinical Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industry
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
Keywords
Where Sensorium Clinical Research is headquartered
LocationHeadquarters
- HQ city
- Philadelphia
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Sensorium Clinical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Clinical Trial Services (Sponsors/CROs): Sensorium generates revenue by delivering clinical trial execution services to pharmaceutical sponsors and CROs through its network of community-based research sites. Revenue is earned per study across the network, with centralized contracting and operations enabling faster study startup, superior enrollment, and consistent data quality.
- Network Membership & Site Support Services: Independent clinical research sites join the Sensorium network in exchange for centralized business development, finance, HR, payroll, compliance, technology systems (CTMS, eReg, CRM), patient recruitment, and regulatory operations support. Sites retain equity and autonomy.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Participant compensation (stipends) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Sensorium Clinical Research product offering
Product offeringCore offering
Sensorium Clinical Research operates a network of independent, community-based clinical trial sites that delivers end-to-end clinical study execution for pharmaceutical sponsors and CROs. The company provides centralized operational infrastructure—including business development, finance, HR, compliance, and technology systems (CTMS, eReg, CRM)—while preserving each site's local brand, culture, and autonomy. Services span site selection, rapid study startup, patient recruitment through trusted community physician networks, study conduct, and inspection-ready data delivery across six therapeutic areas.
Product overview
Sensorium Clinical Research operates as a unified clinical trial site network platform that connects independent research sites while providing centralized operational infrastructure. The core offering consists of the Clinical Trial Site Network platform, which integrates Patient Recruitment Services, Study Conduct & Data Quality Services, and Site Partnership & Infrastructure Support. A technology systems integration support module provides CTMS, eReg, and CRM implementation. The architecture enables independent sites to maintain their local culture and brand while accessing enterprise-grade operational support including business development, finance, HR, compliance, and patient enrollment resources. The network serves three primary segments: patients seeking clinical trial participation, sponsors/CROs seeking reliable site performance, and site owners seeking operational scale without loss of autonomy.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Site Network A network of independent, community-based clinical trial sites connected through centralized operational support, enabling sites to maintain their local culture and autonomy while gaining access to business development, finance, HR, technology systems (CTMS, eReg, CRM), and patient recruitment resources. Sold to pharmaceutical sponsors and CROs as a unified network for clinical trial execution.
- Patient Recruitment Services Multi-channel patient recruitment leveraging trusted local community physician referral networks and community engagement to drive predictable enrollment and retention across therapeutic areas including Neuroscience, Cardiovascular, Gastroenterology, Metabolic, Endocrinology, and Dermatology. Delivered to pharmaceutical sponsors and CROs as part of study execution.
- Study Conduct & Data Quality Services End-to-end clinical trial execution services for sponsors and CROs, including site selection, rapid study startup with streamlined regulatory prep, experienced coordinators with low turnover, real-time data entry, protocol compliance, and inspection-ready documentation across Phase I–IV trials.
- Site Partnership & Infrastructure Support A managed-services engagement for independent clinical research site owners that provides centralized business development, financial infrastructure, HR, payroll, compliance, technology systems (CTMS, eReg, CRM), and patient recruitment support in exchange for joining the Sensorium network. Sites retain their brand, culture, equity, and clinical autonomy.
Quantifiable outcome
- Rapid study startup with streamlined regulatory prep and coordinated IRB/EC submissions
- +3 more outcomes
Companies that use Sensorium Clinical Research
Customer profileSegments3 records
Ideal customer profiles2 records
Sensorium Clinical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Sensorium Clinical Research partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Apex Clinical ResearchcoreApex Clinical Research is a community-based research site located in San Diego, CA, operating as a core member of the Sensorium site network. Led by Site Director Daravan Rath and investigators Dr. Patrick Yassini, Dr. Edward Federman, and Carla Diaz, NP, Apex contributes expertise across multiple therapeutic areas including vaccines, obesity, respiratory, neurology, and dermatology.
- Galiz ResearchcoreGaliz Research is a community-based research site in Hialeah, FL, operating as a core member of the Sensorium site network. Led by Dr. Jose Gamez, MD, a board-certified psychiatrist with 34+ years of experience and 25+ years as Principal Investigator, the site specializes in psychiatric clinical trials from Phase I through Phase IV.
- Quantum Clinical ResearchcoreQuantum Clinical Research is a community-based research site in Deerfield Beach, FL, operating as a core member of the Sensorium site network. Led by Dr. José E. de la Gándara, MD, a licensed adult and geriatric psychiatrist with 30+ years of clinical research experience, the site focuses on CNS indications including Alzheimer's disease, depression, anxiety, bipolar disorder, and schizophrenia.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Sensorium Clinical Research competitors and assessment
Company assessmentDirect peers
- Benchmark Research: Benchmark Research operates community-based clinical trial sites with expertise in vaccines, infectious disease, and general medicine. Comparable to Sensorium as a multi-site, community-rooted clinical trial operator serving pharma sponsors with experienced investigator teams.
- Circuit Clinical: Circuit Clinical is a site network that partners with community physicians to run clinical trials, leveraging referral networks for patient recruitment. Directly comparable to Sensorium in business model (community-rooted site partnership), therapeutic focus, and target customer segments (sponsors/CROs and site owners).
- Velocity Clinical Research: Velocity Clinical Research is one of the largest integrated site networks in the US, operating community-based clinical trial sites across therapeutic areas including CNS, cardiovascular, and metabolic disease. Directly comparable to Sensorium as a multi-therapeutic, community-rooted site network serving pharma sponsors and CROs, though at substantially greater scale (80+ sites).
- Elligo Health Research: Elligo operates a research-ready network of community-based physicians and sites that conduct clinical trials under a 'Goes Direct' model, providing centralized infrastructure to enable independent practices to participate in research. Directly comparable to Sensorium's partnership model of bringing centralized operations to community sites without forcing rebranding.
- Flourish Research: Flourish Research is a multi-site clinical research organization operating community-based sites across the US with therapeutic depth in cardiology, neurology, and metabolic disease. Comparable to Sensorium as a growing SMO-style site network targeting pharma sponsors with multi-therapeutic expertise and centralized operational support.
Regional players
- CMIC Group: CMIC Group is Japan's largest CRO with site network operations across Asia-Pacific and growing US presence. Comparable to Sensorium as a CRO with site operations expertise, though primarily Japan-focused and representing a regional/expansion benchmark rather than a US direct competitor.
Broad incumbents
- IQVIA (Site Network): IQVIA is the world's largest CRO with extensive site management capabilities and preferred-provider relationships across top pharma sponsors. Comparable to Sensorium as a site operations and trial execution provider, but with global reach and integrated technology that small networks like Sensorium cannot match.
- ICON plc: ICON is a global CRO and site services organization with deep therapeutic expertise and integrated site network capabilities. Comparable to Sensorium at the level of clinical trial site execution, but operates as a broad incumbent with substantially greater scale, sponsor relationships, and geographic footprint.
- WCG Clinical: WCG is a broad clinical services platform offering site optimization, IRB, technology, and central laboratory services to trial sites and sponsors. Comparable to Sensorium as a clinical-trial infrastructure provider, but operates at much larger scale and across more services than Sensorium's site-network focus.
Others
- ProPharma Group: ProPharma Group is a life sciences consulting and services firm that acquired Sensorium's predecessor companies (Pharmica Consulting and Intrinsic Clinical Systems) in 2021. Relevant as the acquirer of Sensorium founder Matt Kiernan's prior businesses, providing a credible M&A benchmark for Sensorium's eventual exit trajectory.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Sensorium Clinical Research social profiles
Digital presenceSensorium Clinical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sensorium Clinical Research leadership team
Management profileNumber of profiles
Profiles1 record
Sensorium Clinical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sensorium Clinical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sensorium Clinical Research
What does Sensorium Clinical Research do?
Sensorium Clinical Research operates a network of independent, community-based clinical trial sites that delivers end-to-end clinical study execution for pharmaceutical sponsors and CROs. The company provides centralized operational infrastructure—including business development, finance, HR, compliance, and technology systems (CTMS, eReg, CRM)—while preserving each site's local brand, culture, and autonomy. Services span site selection, rapid study startup, patient recruitment through trusted community physician networks, study conduct, and inspection-ready data delivery across six therapeutic areas.
Is Sensorium Clinical Research a public or private company?
Sensorium Clinical Research is a private company. It is classified as private equity controlled and is currently operating.
When was Sensorium Clinical Research founded?
Sensorium Clinical Research was founded in 2025. It employs 1 to 10 people.
Where is Sensorium Clinical Research based?
Sensorium Clinical Research is headquartered in Philadelphia, United States, in the North America region.
How does Sensorium Clinical Research make money?
Two revenue lines are on record. Clinical Trial Services (Sponsors/CROs) is the primary driver. The others are network Membership & Site Support Services.
Who are Sensorium Clinical Research's main competitors?
Direct peers on record are Benchmark Research, Circuit Clinical, Velocity Clinical Research, Elligo Health Research and Flourish Research. CMIC Group is listed as a regional player. Broad incumbents are IQVIA (Site Network), ICON plc and WCG Clinical. ProPharma Group is listed as an others.
Does Sensorium Clinical Research have an API?
No public API is recorded for Sensorium Clinical Research.
What industry is Sensorium Clinical Research in?
Sensorium Clinical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 5417 and its SIC code is 8731.